List view / Grid view
Introduced at ASMS 2019, the new SYNAPT XS provides ultimate flexibility offering greater freedom of analytical choice to support scientific creativity and technical success for any application.
New state-of-the-art facility will support continued growth and innovation...
Creating access to the power and potential of mass spectrometry for more laboratories...
Next-Generation UPLC Platform designed to keep pace with evolving laboratory requirements for chromatographic performance...
Waters Corporation (NYSE:WAT) today introduced the Waters® ACQUITY™ Arc™ Bio System, a versatile, iron-free, bio-inert, quaternary liquid chromatograph specifically engineered to enable the efficient transfer and improvement of bioseparation analytical methods regardless of the LC platform on which the original method was developed...
Waters Corporation (NYSE:WAT) today introduced BioResolve™ RP mAb Polyphenyl 450 angstrom 2.7 micron solid core Columns intended for the reversed-phase analysis of intact or sub-unit-digested monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs) using LC-UV and LC-MS...
Method transfer or method scaling across different instrument platforms can be affected by both dwell volume and extra-column dispersion...
This application note demonstrates the development of a two-dimensional chromatographic assay for the quantification of trastuzumab, providing up to a three-fold increase in sensitivity compared to 1D LC/MRM.
